IT Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.

Press releases published on November 2, 2026

Nov. 2, 2026

AHA 2026: Heartflow Plaque Analysis Associated with 34% Fewer Major CVD Events and Half the Rate of Heart Attack at One Year in Prospective DECIDE Registry

Indeterminate GlobeNewswire

Nov. 2, 2026

Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study

Indeterminate GlobeNewswire

Nov. 2, 2026

UroGen Announces First Patient Dosed in Phase 1 Trial of UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer

Indeterminate GlobeNewswire

Nov. 2, 2026

Former Microsoft and Cisco Security Executive Edna Conway Joins Known Advisory Council

Indeterminate GlobeNewswire

Nov. 2, 2026

Actuate Therapeutics Receives U.S. Notice of Allowance for Patent Covering Elraglusib Oral Tablets

Indeterminate GlobeNewswire

Nov. 2, 2026

Vera Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 2, 2026

Chemomab Therapeutics and Scipher Medicine Announce SEC Registration Statement on Form S-4 Is Effective

Indeterminate GlobeNewswire

Nov. 2, 2026

NowVertical Announces Resignation of Director

Indeterminate GlobeNewswire

Nov. 2, 2026

Innventure Announces Formation of Strategic Review Committee to Review Range of Capital Strategies

Indeterminate GlobeNewswire

Nov. 2, 2026

Lyell Immunopharma To Participate in November Investor Events

Indeterminate GlobeNewswire

Nov. 2, 2026

Fusemachines Launches New Video Series Showcasing Technology Maturity of HireFoundry.ai's Real-Time Interview Agent

Indeterminate GlobeNewswire

Nov. 2, 2026

SEALSQ to Host “Quantum Days” Event in Cannes as Official Sponsor of the First World Quantum Cannes Festival

Indeterminate GlobeNewswire

Nov. 2, 2026

Enlivex Announces Favorable 12-Month Topline Data from Phase I/IIa Allocetra Trial, Demonstrating Durable Treatment Response

Indeterminate GlobeNewswire

Nov. 2, 2026

AI Innovation Takes Center Stage at PowerPlan ELEVATE 2026

Indeterminate GlobeNewswire

Nov. 2, 2026

Seerist Reports Record Third Quarter 2026: Revenue Up 26%, Federal ARR Up 37%, EBITDA Expands

Indeterminate GlobeNewswire

Nov. 2, 2026

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 2, 2026

SAIC Announces Proposed Offering of $400 Million in Senior Notes

Indeterminate GlobeNewswire

Nov. 2, 2026

Quantum X Labs Announces Cyber Quantum Encryption Breakthrough in Demonstration with IBM Quantum Processor, Heron r2

Indeterminate GlobeNewswire

Nov. 2, 2026

Quantum Cyber Publishes Investor Explanatory Materials on Its Quantum Antenna Technology, Including Technical Summary and Companion Video

Indeterminate GlobeNewswire

Nov. 2, 2026

Crescent Biopharma to Present at November Investor Conferences

Indeterminate GlobeNewswire